Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8483 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.843 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8415 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8409 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8409 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8409 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8389 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8382 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8324 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8314 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8295 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8268 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8266 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8258 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8212 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8208 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8118 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8057 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8046 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8045 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8023 |
Intermediate Similarity |
NPD919 |
Approved |
0.8 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7989 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7978 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7978 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7966 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7933 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7931 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7923 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7898 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7869 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7826 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7809 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7797 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7766 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7754 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7754 |
Intermediate Similarity |
NPD8313 |
Approved |
0.774 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7684 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7676 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7657 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7657 |
Intermediate Similarity |
NPD5403 |
Approved |
0.765 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7556 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7543 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7539 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7527 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD3750 |
Approved |
0.75 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7461 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7458 |
Intermediate Similarity |
NPD920 |
Approved |
0.7457 |
Intermediate Similarity |
NPD1243 |
Approved |
0.745 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7446 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7443 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7443 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7443 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7442 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7438 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD943 |
Approved |
0.7358 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7341 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.734 |
Intermediate Similarity |
NPD7228 |
Approved |
0.733 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7327 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7327 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD7874 |
Approved |
0.731 |
Intermediate Similarity |
NPD1607 |
Approved |
0.73 |
Intermediate Similarity |
NPD6779 |
Approved |
0.73 |
Intermediate Similarity |
NPD6781 |
Approved |
0.73 |
Intermediate Similarity |
NPD6777 |
Approved |
0.73 |
Intermediate Similarity |
NPD6776 |
Approved |
0.73 |
Intermediate Similarity |
NPD6780 |
Approved |
0.73 |
Intermediate Similarity |
NPD6778 |
Approved |
0.73 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7288 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7283 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7283 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7283 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7283 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7282 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7282 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7253 |
Intermediate Similarity |
NPD37 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7236 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7228 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7228 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7225 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7225 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7216 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7192 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7192 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7192 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7184 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7159 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7159 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7151 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7136 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7098 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7088 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7074 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.705 |
Intermediate Similarity |
NPD6535 |
Approved |
0.705 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7033 |
Intermediate Similarity |
NPD7801 |
Approved |
0.703 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.699 |
Remote Similarity |
NPD8319 |
Approved |
0.6982 |
Remote Similarity |
NPD1203 |
Approved |
0.6979 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD7907 |
Approved |
0.6977 |
Remote Similarity |
NPD3764 |
Approved |
0.6977 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6974 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6959 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6949 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6947 |
Remote Similarity |
NPD5711 |
Approved |
0.6947 |
Remote Similarity |
NPD5710 |
Approved |
0.6947 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6936 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6923 |
Remote Similarity |
NPD7240 |
Approved |
0.6897 |
Remote Similarity |
NPD1613 |
Approved |
0.6897 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD6099 |
Approved |
0.6893 |
Remote Similarity |
NPD6100 |
Approved |
0.6893 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6891 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6879 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6878 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD7680 |
Approved |
0.6857 |
Remote Similarity |
NPD1933 |
Approved |
0.6856 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6854 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6836 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6835 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6833 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6823 |
Remote Similarity |
NPD5242 |
Approved |
0.6809 |
Remote Similarity |
NPD2296 |
Approved |
0.6806 |
Remote Similarity |
NPD4665 |
Approved |
0.6806 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6805 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6789 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD2403 |
Approved |
0.6788 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD3268 |
Approved |
0.6782 |
Remote Similarity |
NPD411 |
Approved |
0.6763 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6761 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6751 |
Remote Similarity |
NPD7039 |
Approved |
0.6751 |
Remote Similarity |
NPD7038 |
Approved |
0.6739 |
Remote Similarity |
NPD6273 |
Approved |
0.6724 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6724 |
Remote Similarity |
NPD7095 |
Approved |
0.672 |
Remote Similarity |
NPD4288 |
Approved |
0.6718 |
Remote Similarity |
NPD2163 |
Approved |
0.6717 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6706 |
Remote Similarity |
NPD9717 |
Approved |
0.6703 |
Remote Similarity |
NPD2354 |
Approved |
0.6686
|
Remote Similarity |
NPD2797 |
Approved |